1315 Capital β Full Portfolio
43 tracked investments Β· listed companies and verified rows first
BiotechMalvern, US
Vince Burgass(Director)Kevin Rakin(Director)Ashley Freidman(Director)Francis Conway(Executive Officer)Maarten Persenaire(Executive Officer)Antony Koblish(Executive Officer, Director)
Board seatAdele C. OlivaΒ· per SEC Form D Β· $7.5M raise Β· filed Jan 2017
HealthtechParsippany, US
Christopher McCarthy(Chief Financial Officer)Thomas W. Burnell(Executive Officer, Director)James Early(CFO)Jack E Stover(President and CEO)
BoardStephen J. Sullivan(Director)Vijay Aggarwal(Director)
HealthtechMalvern, US
Mark R. Bausinger(Executive Officer)Stephen Campe(Director)Robert Kuhling(Director)Liam Ratcliffe(Director)P. Sherrill Neff(Director)Wilfred Jaeger(Director)
HealthtechCarlsbad, US
Stephen Loomis(Executive Officer)M Bolyard(Director)Brian Dovey(Director)Josh Baltzell(Director)Mary Fisher(Executive Officer, Director)Daniell Turner III(Director)
Board seatAdele C. OlivaΒ· per SEC Form D
HealthtechMalvern, US
Robert Moccia(Executive Officer, Director)Jay K. Hachigian(Executive Officer)
Board seatAdele C. OlivaΒ· per SEC Form D
HealthtechToronto
William Leonard(Executive Officer, Director)Diana Shi(Executive Officer)Frank Tworecke(Director)Euphia Hsu Smith(Executive Officer)Erns Loubser(Executive Officer)Brian P. Burke(Director)
Board seatAdele C. OlivaΒ· per SEC Form D Β· $15.7M raise Β· filed Jul 2022
HealthtechGlen Burnie, US
Eran Nadav(Director)Jack Stoddard(Director)Mark Janofsky(Executive Officer)Greg Stokes(Executive Officer)John Spitznagel(Executive Officer, Director)Steve Grenfell(Director)
Board seatAdele C. OlivaΒ· per SEC Form D Β· $7.5M raise Β· filed Jun 2019
Onkos Surgical develops orthopaedic implants and an FDA-granted antibacterial coating technology intended to protect implants from bacteria at the time of surgery.
HealthtechMedical DevicesParsippany, US
Board seatAdele C. OlivaΒ· per SEC Form D
HealthtechNewport News, US
William R. Easby-Smith(Director)Gordon Berkstresser(Director)Allan R. Staley(Executive Officer, Director)T. Kerry McCarter(Executive Officer, Director)Guy G. Levy(Executive Officer, Director)David Kaufman(Director)
Board seatMichael KobyΒ· per SEC Form D Β· $28.3M raise Β· filed Nov 2017
Spineology develops OptiMesh, a conformable mesh interbody fusion device that is placed in the disc space through a small portal and filled with bone graft in-situ to restore disc height, achieve spinal alignment, and promote fusion.
BiotechHealthtechMedical DevicesSt. Paul, US
JAMISON YOUNG(Executive Officer)BRIAN SNIDER(Executive Officer, Director)Donald R. Brattain(Director)Edson W. Spencer(Director)John J. Booth(Executive Officer, Director)James T. Rybicki(Director)
Board seatCraig MatturroΒ· per SEC Form D
BiotechRaleigh, US
Margaret Henry(Executive Officer)Cynthia Eckert(Executive Officer, Director)Adele Oliva(Director)Eric Atkins(Executive Officer)Cynthia Whitehead(Executive Officer, Director)
BoardSandra McGlothlin(Director)
Board seatAdele C. OlivaΒ· per SEC Form D Β· $6.6M raise Β· filed Jan 2018
Molecular diagnostics company offering clinical PCR systems using automation and microfluidics; acquired by QIAGEN in September 2020.
BiotechHealthtechAlbuquerque, US
Thomas Duensing(Executive Officer)Dennis Hynson(Executive Officer)Jack T. Ball(Director)J. Michael Schafer(Director)Janette Phi(Executive Officer)Bo E.H. Saxberg(Director)
Medical equipment liquidation and resale platform specializing in auctions and facility liquidations; grew into the world's largest medical equipment auction house before being acquired by TRIMEDX in 2020.
Cranbury, US
David Wood(Executive Officer, Director)
BoardDerek Hennecke(Director)Matthew Reber(Director)Thomas Weller(Director)William Mitchell(Director)Andrew Frazier(Director)
Company specializing in cell nutrient innovation and raw material expertise, referenced in a portfolio press release.
Nutrisense provides personalized metabolic monitoring and health guidance through continuous glucose monitoring and data analysis.
Digital HealthHealthtechWellness & FitnessChicago, US
Kara Collier(Cofounder)Aleksey Skryl(Executive Officer, Director)Bogdan Zavorotny(Director, Executive Officer)Jessica Hou(Director)
BoardMichael Satow(Director)
BiotechSan Diego, US
Helge Zieler(Director, Executive Officer)
BoardJ. Todd Mitchell(Director)Matthew Korenberg(Director)Matthew Reber(Director)Wes Kaupinen(Director)
Seraphina Therapeutics develops food- and nature-based consumer health products, starting with the fatty acid C15:0 (pentadecanoic acid), aimed at replenishing micronutrients and metabolites that decline with age.
ConsumerLongevityWellness & Fitness
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.